Yana Zhang

Dr. Yana Zhang

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2022 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
YLYue Li
Yue Li
LCLi-Hong Chang
Li-Hong Chang
WHWei-Qiang Huang
Wei-Qiang Huang
HBHong-Wei Bao
Hong-Wei Bao
XLXia Li
Xia Li
GZGehua Zhang
Gehua Zhang

23 November 2022 in Science Advances
Verified
Journal Article
Open access
EMElena Montauti
Elena Montauti
SWSamuel Weinberg
Samuel Weinberg
PCPeng Chu
Peng Chu
SCShuvam Chaudhuri
Shuvam Chaudhuri
NMNikita L. Mani
Nikita L. Mani
DFDeyu Fang
Deyu Fang
The tumor microenvironment (TME) enhances regulatory T (T reg ) cell stability and immunosuppressive functions through up-regulation of lineage transcription factor Foxp3, a phenomenon known as T reg fitness or adaptation. Here, we characterize previously unknown TME-specific cellular and molecular mechanisms underlying T reg fitness. We demonstrate that TME-specific stressors including transforming growth factor–β (TGF-β), hypoxia, and nutrient deprivation selectively induce two Foxp3-specific deubiquitinases, ubiquitin-specific peptidase 22 ( Usp22 ) and Usp21 , by regulating TGF-β, HIF, and mTOR signaling, respectively, to maintain T reg fitness. Simultaneous deletion of both USPs in T reg cells largely diminishes TME-induced Foxp3 up-regulation, alters T reg metabolic signatures, impairs T reg -suppressive function, and alleviates T reg suppression on cytotoxic CD8 + T cells. Furthermore, we developed the first Usp22 -specific small-molecule inhibitor, which dramatically reduced intratumoral T reg Foxp3 expression and consequently enhanced antitumor immunity. Our findings unveil previously unappreciated mechanisms underlying T reg fitness and identify Usp22 as an antitumor therapeutic target that inhibits T reg adaptability in the TME.

2 June 2025 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
HWHai Wang
Hai Wang
DHDanqing Hu
Danqing Hu
YCYang Cheng
Yang Cheng
QGQiong Gao
Qiong Gao
KLKun Liu
Kun Liu
DFDeyu Fang
Deyu Fang

2 November 2021 in Arthritis & Rheumatology
Verified
Journal Article
Closed access
PDF file
YZYana Zhang
Yana Zhang
MGMing Gui
Ming Gui
YWYajun Wang
Yajun Wang
NMNikita Mani
Nikita Mani
SCShuvam Chaudhuri
Shuvam Chaudhuri
DFDeyu Fang
Deyu Fang

22 November 2022 in Clinical and Translational Allergy
Verified
Journal Article
Open access
WCWenyi Chen
Wenyi Chen
YBYurong Bai
Yurong Bai
WKWeifeng Kong
Weifeng Kong
XLXin Luo
Xin Luo
YZYinhui Zeng
Yinhui Zeng
YZYana Zhang
Yana Zhang
Background: Charcot‐Leyden crystals (CLCs) are recognized to be classic hallmarks of eosinophilic inflammation. Both protein and mRNA levels of CLC in nasal secretions and nasal brushing samples have been associated with nasal polyp recurrence. However, whether the crystalline CLC structures in nasal tissue could serve as an effective biomarker to predict polyp recurrence remains unclear.Methods: A total of 110 patients with chronic rhinosinusitis with nasal polyps (CRSwNP) completing the postoperative follow‐up over a period of 24 months were recruited. Hematoxylin and eosin staining was employed for CLCs identification. The predictive factors for polyp recurrence were determined by binary logistic regression analysis.Results: Thirty three (30.00%) patients developed recurrence during a 24‐month postoperative follow‐up, in which 84.85% (28/33) patients had crystalline CLC structures. Logistic regression analysis showed that crystalline CLC structure in nasal tissues is predictive of polyp recurrence. Youden index demonstrated crystalline CLC structure higher than 1 per high power field can predict postoperative polyp recurrence with 84.80% sensitivity and 98.70% specificity.Conclusions: The crystalline CLC structures in nasal tissues may serve as an easy‐counting and promising biomarker to predict CRSwNP recurrence.

1 March 2022 in Journal of Asthma and Allergy
Verified
Journal Article
Open access
PDF file
WKWeifeng Kong
Weifeng Kong
QWQingwu Wu
Qingwu Wu
YCYubin Chen
Yubin Chen
YRYong Ren
Yong Ren
WWWeihao Wang
Weihao Wang
YZYana Zhang
Yana Zhang
Purpose: Histopathologic characterizations of central compartment atopic disease (CCAD) by whole-slide imaging remains lacking. We aim to study clinical presentations and cellular endotyping diagnosis of Chinese CCAD using artificial intelligence (AI). Methods: A total of 72 patients diagnosed with chronic rhinosinusitis with nasal polyps (CRSwNP) were enrolled. CCAD was defined by positive result of serology specific IgE, endoscopic and radiological findings. The aeroallergen sensitization status, endoscopic results, radiological findings, and symptoms were evaluated and compared between patients with CCAD (n=14), eosinophilic CRSwNP (ENP, n=32) and non-eosinophilic CRSwNP (NENP, n=26). The cellular endotypes including eosinophils, neutrophils, lymphocytes, and plasma cells were analyzed by the AI chronic rhinosinusitis evaluation platform 2.0. Results: CCAD was most common in male (71.43%). The positive rate of aeroallergen in patients with CCAD is 100%, which is much higher than those in patients with ENP (40.63%) and NENP (23.08%). Allergic rhinitis incidence was found to be 57.14% in Chinese CCAD subjects, which is obviously higher when compared with those in patients with ENP (21.88%) or NENP (0.00%). The presence of asthma was not significantly different between groups. Chinese CCAD population demonstrated mild symptoms and lower endoscopic and radiological scores than those in patients with ENP and NENP. For cellular endotypes in CCAD subjects, the median of eosinophils, neutrophils, lymphocytes, and plasma cells was 26.55%, 0.49%, 60.85%, and 7.33%, respectively. The proportion of eosinophils in nasal tissue and peripheral blood mononuclear cells from the CCAD group is between the proportions in those patients with ENP and NENP. Conclusion: Chinese CCAD was associated with aeroallergen sensitivity, and displayed an eosinophil-dominant inflammatory pattern. Thus, proper management with allergy control and topical steroids could be recommended for CCAD treatment.